Leonard Reyno

Company: Pionyr Immunotherapeutics

Job title: CMO

Seminars:

Reprogramming TREM1+ Myeloid Cells to Overcome Immunotherapy Resistance in Solid Tumors 10:00 am

• Exemplifying how depletion of different myeloid cell subsets can affect different features of the tumor microenvironment, modulate effector cell activity, and promote tumorigenesis • Discussing the tolerability of different targets • Drawing up next steps in clinical development for myeloid-targeting therapiesRead more

day: Day Two